We also explored the correlations of the six genes with the prognosis of HCC patients using the UALCAN database and found that HCC patients with high GMIP, MOBKL2A, ARPC2, CD68, or FAM102B expression had a significantly worse prognosis (Fig. S4). The gene discussed is ARPC2; the disease is hepatocellular carcinoma.